TY - JOUR T1 - Pharmacogenomic testing: Relevance in medical practice JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 243 LP - 257 DO - 10.3949/ccjm.78a.10145 VL - 78 IS - 4 AU - Joseph P. Kitzmiller AU - David K. Groen AU - Mitch A. Phelps AU - Wolfgang Sadee Y1 - 2011/04/01 UR - http://www.ccjm.org/content/78/4/243.abstract N2 - Genetics may account for much of the variability in our patients’ responses to drug therapies. This article offers the clinician an up-to-date overview of pharmacogenomic testing, discussing implications and limitations of emerging validated tests relevant to the use of warfarin (Coumadin), clopidogrel (Plavix), statins, tamoxifen (Nolvadex), codeine, and psychotropic drugs. It also discusses the future role of pharmacogenomic testing in medicine. ER -